abstract |
The present invention relates to a form of 9 - [(R) -2 - [[(S) - [[(S) -1- (isopropoxycarbonyl) -ethyl] amino] phenoxyphosphinyl] methoxy] propyl] adenine hemifumarate ( tenofovir alafenamide), and antiviral therapy using tenofovir alafenamide hemifumarate (for example, anti-HIV and anti-HBV therapies). |